Non-HLA barriers to unrelated donor stem cell transplantation

Bone Marrow Transplantation

Volumn 27, Issue 6, 2001, Pages 581-587

  Kollman, C ^a   Weis, T ^a   Switzer, G E ^b   Halet, M ^a   Kitajima, D ^a   Hegland, J ^a   Confer, D L ^a  

^a NATIONAL MARROW DONOR PROGRAM   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Barriers; Registry; Search; Survey; Unrelated

Indexed keywords

HLA ANTIGEN;

ADULT; AFRICA; AGED; ARTICLE; ASIAN; CANCER CHEMOTHERAPY; CHILD; CONTROLLED STUDY; DEATH; DONOR; FEMALE; FINANCIAL MANAGEMENT; FOLLOW UP; HEALTH CENTER; HEALTH SURVEY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA TYPING; HUMAN; IMMUNOTHERAPY; INFANT; MALE; MEDICAL DECISION MAKING; PACIFIC ISLANDS; PATIENT REFERRAL; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; RELATIVE; TIME; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; DECISION MAKING; FEMALE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; REFUSAL TO TREAT; REGISTRIES; TISSUE DONORS;

EID: 0035032747     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702845     Document Type: Article

References (16)

1. Transplantation of marrow from an unrelated donor to a patient with acute leukemia
2. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies
3. Analysis of 462 transplants from unrelated donors facilitated by the National Marrow Donor Program
4. The National Marrow Donor Program: How it works, accomplishments to date
5. The origins and development of the National Marrow Donor Program
6. Standards of the National Marrow Donor Program
7. The US National Marrow Donor Program
8. Impact of racial genetic polymorphism upon the probability of finding an HLA-matched donor
9. Factors associated with attrition from a national bone marrow registry
10. Hematopoietic cell donor registries
11. Matched unrelated transplants
12. Unrelated-donor marrow transplants: The experience of the National Marrow Donor Program
13. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation
14. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation
15. Definition of HLA-DQ as a transplantation antigen
16. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors